Endpoints News 6. Feb. 2026 Illumina bets on healthcare after Trump administration's NIH funding disruptions
Endpoints News 5. Feb. 2026 #ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Endpoints News 5. Feb. 2026 Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
Endpoints News 5. Feb. 2026 Telehealth provider Hims goes after Novo's weight loss pill with compounded version
Endpoints News 4. Feb. 2026 AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira
Endpoints News 4. Feb. 2026 Rare pediatric PRV program reauthorized until 2029 via government funding law
Endpoints News 4. Feb. 2026 Midi Health raises $100M as it plans expansion into urgent care, research